Andere talen Johnson & Johnson

Aandelen

JNJ

US4781601046

Geschatte realtime Cboe BZX Andere beurzen 15:40:34 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
146,8 ^USD	-0,04%		+0,74%	-6,33%

25/04	JOHNSON & JOHNSON : Redburn Atlantic handhaaft het Neutraal advies	ZM
24/04	Simponi Biosimilar-kandidaat van Alvotech toont werkzaamheid in bevestigende studie	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

FDA Approval Of Alvotech/Teva Ustekinumab Biosimilar	10:12
Cidara Therapeutics Shares Surge 42% After Re-Acquiring Flu Asset	24/04
Alvotech’s Simponi Biosimilar Candidate Shows Efficacy in Confirmatory Study	24/04
Welfare Plan Class Action Litigation Underscores Importance Of Minding Your Fiduciary Duties	24/04
Johnson & Johnson to participate in the Bernstein's 40th Annual Strategic Decisions Conference	23/04
Janssen - CARVYKTI is the first BCMA-targeted treatment approved by the European Commission for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy	23/04
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)	22/04
J&J : feu vert de l'UE pour Carvykti dans le myélome multiple	22/04
Johnson & Johnson : CARVYKTI®▼ (ciltacabtagene autoleucel; cilta-cel) is the first BCMA-targeted treatment approved by the European Commission for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy	22/04
Contaminated cough syrup in Africa no longer available - WHO	22/04
WHO Likely to Issue Wider Warning About J&J Cough Syrup Contamination, Reuters Reports	19/04
La OMS ve "probable" una alerta más amplia por un jarabe para la tos de J&J contaminado	19/04
WHO says wider alert on contaminated J&J cough syrup 'likely'	19/04
US FDA mandates label updates on CAR-T cancer therapies	19/04
Medical device maker Intuitive beats estimates on strong demand for surgical robots	18/04
Johnson & Johnson : First Quarter 2024 2024 First-Quarter Earnings Transcript	18/04
Johnson & Johnson's Q1 Had 'Some Puts and Takes,' Morgan Stanley Says	17/04
Johnson & Johnson Reports Q1 2024 Results	17/04
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase, Raises Quarterly Dividend by 4.2%	17/04
Planisware: la pequeña estrella francesa del software sale a bolsa, al estilo ninja	17/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Headlines

De geneesmiddelenpijplijn is goed gepositioneerd voor 2024, zegt J&J CFO

23 januari 2024 om 18:30 uur